Short description
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Description
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor immunity pathways. The company has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct pathways relevant to mounting an effective anti-tumor response.
Tempest Therapeutics was established in 2011 and is headquartered in San Francisco, California.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2011
Exited on
June 28, 2021
Went public on
June 28, 2021
Stock symbol
TPST
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccess, Absolutely Noaccess, Cannot Access, Noaccess, Nopepepe, Noaccess
Sign in for full access
Founders
Stephen Brady, Thomas W. Dubensky